Petros Pharmaceuticals, Inc.
General ticker "PTPI" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $79.8M (TTM average)
Petros Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -13.8%.
Estimated limits based on current volatility of 7.4%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 24 as of 2022
- US accounted for 77.7% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Liquidity and credit risks, Pandemic risks, Commercialization challenges, Labor/talent shortage/retention, Market dependence
- Current price 99.8% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [11.68$, 40.45$]
- 2024-12-30 to 2025-12-30 estimated range: [6.36$, 23.75$]
Financial Metrics affecting the PTPI estimates:
- Negative: with PPE of -0.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -16.53 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Interest expense per share per price, % of 1.16 <= 3.41
- Positive: 18.93 < Shareholder equity ratio, % of 35.72 <= 41.86
Short-term PTPI quotes
Long-term PTPI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $7.81MM | $5.99MM | $5.82MM |
| Operating Expenses | $25.86MM | $25.91MM | $19.44MM |
| Operating Income | $-18.05MM | $-19.92MM | $-13.62MM |
| Non-Operating Income | $9.06MM | $-0.12MM | $5.45MM |
| Interest Expense | $0.37MM | $0.60MM | $0.54MM |
| R&D Expense | $1.79MM | $1.74MM | $2.41MM |
| Income(Loss) | $-8.99MM | $-20.04MM | $-8.16MM |
| Profit(Loss)* | $-8.99MM | $-20.04MM | $-8.16MM |
| Stockholders Equity | $35.54MM | $16.70MM | $12.07MM |
| Inventory | $0.52MM | $1.82MM | $1.61MM |
| Assets | $67.39MM | $32.42MM | $33.80MM |
| Operating Cash Flow | $-11.86MM | $-12.80MM | $-7.63MM |
| Financing Cash Flow | $18.57MM | $-1.62MM | $11.54MM |
| Earnings Per Share** | $-8.25 | $-9.68 | $-6.35 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.